These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34950326)

  • 1. Cardiac Resynchronization Therapy in continuous flow Left Ventricular Assist Device Recipients: A Systematic Review and Meta-analysis from ELECTRAM Investigators.
    Shah K; Karpe V; K Turagam M; Shah M; Natale A; Gopinathannair R; Lakkireddy D; Garg J
    J Atr Fibrillation; 2020 Dec; 13(4):2441. PubMed ID: 34950326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
    Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
    J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of QRS Duration and Ventricular Pacing on Clinical and Arrhythmic Outcomes in Continuous Flow Left Ventricular Assist Device Recipients: A Multicenter Study.
    Gopinathannair R; Roukoz H; Trivedi JR; Cowger J; Bhan A; Ravichandran A; Bhat G; Birks EJ; Slaughter MS; Ahmed MM
    J Card Fail; 2019 May; 25(5):355-363. PubMed ID: 30797964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued versus Suspended Cardiac Resynchronization Therapy after Left Ventricular Assist Device Implantation.
    Roukoz H; Bhan A; Ravichandran A; Ahmed MM; Bhat G; Cowger J; Abdullah M; Dhawan R; Trivedi JR; Slaughter MS; Gopinathannair R
    Sci Rep; 2020 Feb; 10(1):2573. PubMed ID: 32054868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
    Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Implantable cardioverter-defibrillators in Continuous-flow Left Ventricular Assist Device Recipients.
    Shah K; Chaudhary R; K Turagam M; Shah M; Patel B; Lanier G; Lakkireddy D; Garg J
    J Atr Fibrillation; 2021; 14(1):20200490. PubMed ID: 34950365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy and outcomes in patients with left ventricular assist devices: a systematic review and meta-analysis.
    Voruganti DC; Briasoulis A; Chaudhry M; Alvarez P; Cotarlan V; Bhama JK; Giudici M
    Heart Fail Rev; 2019 Mar; 24(2):229-236. PubMed ID: 30259285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy.
    Adelstein EC; Schwartzman D; Jain S; Bazaz R; Wang NC; Saba S
    Europace; 2017 Oct; 19(10):1689-1694. PubMed ID: 27856539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and outcomes of patients with ventricular arrhythmias after continuous-flow left ventricular assist device implant.
    Gulletta S; Scandroglio AM; Pannone L; Falasconi G; Melisurgo G; Ajello S; D'Angelo G; Gigli L; Lipartiti F; Agricola E; Lapenna E; Castiglioni A; De Bonis M; Landoni G; Bella PD; Zangrillo A; Vergara P
    Artif Organs; 2022 Aug; 46(8):1608-1615. PubMed ID: 35292988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Continued Cardiac Resynchronization Therapy on Ventricular Arrhythmias After Left Ventricular Assist Device Implantation.
    Schleifer JW; Mookadam F; Kransdorf EP; Nanda U; Adams JC; Cha S; Pajaro OE; Steidley DE; Scott RL; Carvajal T; Saadiq RA; Srivathsan K
    Am J Cardiol; 2016 Aug; 118(4):556-9. PubMed ID: 27328958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of ventricular arrhythmia in cardiac resynchronization therapy responders and super-responders: a systematic review and meta-analysis.
    Yuyun MF; Erqou SA; Peralta AO; Hoffmeister PS; Yarmohammadi H; Echouffo Tcheugui JB; Martin DT; Joseph J; Singh JP
    Europace; 2021 Aug; 23(8):1262-1274. PubMed ID: 33496319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction.
    McAlister FA; Ezekowitz J; Dryden DM; Hooton N; Vandermeer B; Friesen C; Spooner C; Rowe BH
    Evid Rep Technol Assess (Full Rep); 2007 Jun; (152):1-199. PubMed ID: 17764218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillator-related procedures and associated complications in continuous flow left ventricular assist device recipients: A multicenter experience.
    Ravichandran A; Pothineni NVK; Trivedi JR; Roukoz H; Ahmed MM; Bhan A; Bhat G; Cowger J; Al Ahmad A; Natale A; Di Biase L; Slaughter MS; Lakkireddy D; Gopinathannair R
    Heart Rhythm O2; 2021 Dec; 2(6Part B):691-697. PubMed ID: 34988518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis.
    Adabag S; Roukoz H; Anand IS; Moss AJ
    J Am Coll Cardiol; 2011 Aug; 58(9):935-41. PubMed ID: 21851882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable Cardioverter-Defibrillator Use in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis.
    Vakil K; Kazmirczak F; Sathnur N; Adabag S; Cantillon DJ; Kiehl EL; Koene R; Cogswell R; Anand I; Roukoz H
    JACC Heart Fail; 2016 Oct; 4(10):772-779. PubMed ID: 27395347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Cardiac Resynchronization Therapy on Ventricular Arrhythmias and Survival After Durable Left Ventricular Assist Device Implantation.
    Oates CP; Lawrence LL; Bigham GE; Meda NS; Basyal B; Rao SD; Hadadi CA; Najjar SS; Shah MH; Sheikh FH; Lam PH
    ASAIO J; 2024 Jul; ():. PubMed ID: 39074441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
    Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
    Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A systematic review and meta-analysis on efficacy and safety of cardiac resynchronization therapy alone or in combination with implantable cardioversion defibrillation in patients with mild to severe heart failure].
    Tu RH; Peng RL; Zhong GQ; Wu WF; Chen L; Liang YY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):161-70. PubMed ID: 23710749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators and survival in advanced heart failure patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis.
    Elkaryoni A; Badarin FA; Khan MS; Ellakany K; Potturi N; Poonia J; Kennedy KF; Magalski A; Sperry BW; Wimmer AP
    Europace; 2019 Sep; 21(9):1353-1359. PubMed ID: 31086951
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.